Our experiments showed that this new delivery system could help MIL5scFv overcome the hurdle of the NIH3T3 cell membrane (HER2 negative), and retaining or even improving the specificity of the cargo protein to identify HER2 over-expressing tumour cell line SKOV3. Here, ERBB2 is linked to neoplasm.